| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 316 |
| 1 | CAPECITABINE | 248 |
| 2 | PACLITAXEL | 242 |
| 3 | OXALIPLATIN | 239 |
| 4 | PACLITAXEL (AIBUMIN-BOUND) | 214 |
| 5 | CARBOPLATIN | 198 |
| 6 | LETROZOLE | 194 |
| 7 | FLUOROURACIL | 177 |
| 8 | FLUOROURACIL CREAM, 0.5% | 176 |
| 9 | GEMCITABINE HYDROCHLORIDE | 170 |
| # | Drug class | Count |
|---|---|---|
| 0 | Platinum-based Drug [EPC] | 516 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 411 |
| 2 | Kinase Inhibitor [EPC] | 373 |
| 3 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 326 |
| 4 | Microtubule Inhibitor [EPC] | 320 |
| 5 | Aromatase Inhibitor [EPC] | 238 |
| 6 | Corticosteroid [EPC] | 179 |
| 7 | Estrogen Receptor Antagonist [EPC] | 148 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 133 |
| 9 | Alkylating Drug [EPC] | 132 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 14 | 0.0092 |
| 1 | Actinomycin [EPC] | 14 | 0.0063 |
| 2 | Lymphocyte Activation Gene-3 Blocker [EPC] | 2 | 0.0039 |
| 3 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 82 | 0.0038 |
| 4 | Estrogen Receptor Antagonist [EPC] | 148 | 0.0036 |
| 5 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 21 | 0.0033 |
| 6 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 7 | Vitamin B6 Analog [EPC] | 1 | 0.0028 |
| 8 | Lymphocyte Growth Factor [EPC] | 3 | 0.0024 |
| 9 | Sclerosing Agent [EPC] | 1 | 0.0022 |